Zai Lab's repotrectinib label expansion accepted in China for treating advanced solid tumors with NTRK gene fusion.
https://seekingalpha.com/news/4432749-zai-lab-gets-chinas-acceptance-for-label-expansion-of-repotrectinib
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.